BSFAF (BSF Enterprise) Common Stock: $1.71 Mil (As of Mar. 2026)


What is BSF Enterprise Common Stock?

BSF Enterprise BSFAF Common Stock is $1.71 Mil as of Mar. 2026. The stock has 3 warning signs investors should review.

BSF Enterprise's quarterly common stock increased from Mar. 2025 ($1.60 Mil) to Sep. 2025 ($1.74 Mil) but then declined from Sep. 2025 ($1.74 Mil) to Mar. 2026 ($1.71 Mil).

BSF Enterprise's annual common stock increased from Sep. 2023 ($1.28 Mil) to Sep. 2024 ($1.37 Mil) and increased from Sep. 2024 ($1.37 Mil) to Sep. 2025 ($1.74 Mil).

BSF Enterprise Common Stock Historical Data

* Premium members only.

The historical data trend for BSF Enterprise's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BSF Enterprise Common Stock Chart

BSF Enterprise Annual Data
Trend Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Common Stock
Get a 7-Day Free Trial 0.28 0.97 1.28 1.37 1.74

BSF Enterprise Semi-Annual Data
Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.31 1.37 1.60 1.74 1.71

BSF Enterprise Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $1.71 Mil mean?
BSF Enterprise (BSFAF) has a Common Stock of $1.71 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on BSF Enterprise and its competitors.
Is BSF Enterprise's Common Stock too high?
BSF Enterprise's current Common Stock is $1.71 Mil.
How does BSF Enterprise's Common Stock compare to VRTX and REGN?
BSF Enterprise's Common Stock of $1.71 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on BSF Enterprise and its competitors. BSF Enterprise's current Common Stock is $1.71 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BSF Enterprise stock overvalued right now?
BSF Enterprise (BSFAF) has a current Common Stock of $1.71 Mil. The current Common Stock is $1.71 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For BSF Enterprise (BSFAF), the current Common Stock is $1.71 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BSF Enterprise Business Description

Other Exchanges BSFA:UK
Address 2 Portman Street, London, GBR, W1H 6DU
BSF Enterprise PLC is a United Kingdom-based biotech company. The Company is focused on developing biotechnological solutions using cell-based tissue engineering to help generate cultured meat, lab-grown leather, as well as human corneas, collagen growth and skin substitutes. The Company operates through its wholly owned subsidiary, 3D Bio-Tissues Limited (3DBT), which is a clinical and cellular agriculture company engaged in producing human corneas that could help restore vision to millions of people.